GXDW Performance — Global X Dorsey Wright Thematic ETF
Data updated: 2026-07-29
GXDW returned +26.48% year to date and +26.14% over one year to May 2026. Annualised returns are +7.99% over 3 years and −7.60% over 5 years. Against its Thematic Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $126, against $175 for the category, and to $126 over one year, against $125. Volatility over the past three years was 25.20% a year. In the 12 months to May 2026 the fund lost a net $3.0M, and assets reached $8.51M.
GXDW Growth of $100
What $100 invested in Global X Dorsey Wright Thematic ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Thematic Equity category average over the same months.
| Period | GXDW | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $126 | $125 |
| 3 years (Jun 2023 – May 2026) | $126 | $175 |
| 5 years (Jun 2021 – May 2026) | $67 | $149 |
| Since data start (Sep 2019 – May 2026) | $130 | $237 |
GXDW Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +26.48% |
| 1 year | +26.14% |
| 3 years (annualised) | +7.99% |
| 5 years (annualised) | −7.60% |
GXDW Annual Returns
Calendar-year total returns of Global X Dorsey Wright Thematic ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +26.48% |
| 2025 | −3.35% |
| 2024 | +6.34% |
| 2023 | +2.67% |
| 2022 | −46.47% |
| 2021 | +4.92% |
| 2020 | +75.03% |
| 2019 (Sep–Dec) | −1.04% |
GXDW Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.9% | −4.7% | +10.5% | +23.1% | −6.1% | — | — | — | — | — | — | — |
| 2025 | +2.6% | −7.4% | +6.9% | +1.5% | −6.0% | +1.9% | +0.9% | +5.6% | −9.0% | +1.6% | +3.9% | −4.3% |
| 2024 | −9.1% | +8.8% | +4.7% | −5.6% | +1.6% | 0.0% | +3.7% | −4.9% | +3.0% | −2.6% | +8.5% | −0.4% |
| 2023 | +19.1% | −11.5% | +1.1% | −2.0% | +1.6% | −11.5% | +8.5% | +6.1% | +8.8% | −10.1% | −7.9% | +5.6% |
| 2022 | −13.1% | −5.3% | −0.9% | −14.5% | +0.1% | −2.6% | +6.6% | −7.5% | −2.5% | +3.2% | −13.9% | −7.7% |
| 2021 | +11.2% | +3.6% | −1.8% | +3.4% | −4.9% | +5.2% | −2.4% | +6.8% | −7.0% | +3.0% | −6.4% | −4.1% |
| 2020 | +0.7% | +3.0% | +12.1% | +16.9% | −14.6% | +6.8% | +8.7% | +7.0% | +23.1% | +1.8% | −6.3% | +3.2% |
| 2019 | — | — | — | — | — | — | — | — | +4.3% | 0.0% | 0.0% | −5.1% |
GXDW Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 25.20%
- 3-year Sharpe ratio: 0.14 (vs 4.5% risk-free rate)
- Best month: +23.14% (Apr 2026)
- Worst month: −11.48% (Jun 2023)
GXDW Fund Flows
Monthly money in and out of Global X Dorsey Wright Thematic ETF, from SEC Form N-PORT.
- 12-month net flow: −$3.0M
- 12-month gross sales (incl. reinvestments): $1.7M
- Sales ÷ redemptions: 0.36×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $942K | −$942K |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $1.2M | $1.4M | −$227K |
| Feb 2026 | $0 | $769K | −$769K |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $562K | $1.7M | −$1.1M |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
| Jun 2025 | $0 | $0 | $0 |
GXDW Assets Under Management
Net assets of Global X Dorsey Wright Thematic ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $8.51M |
| 2026-02-28 | $7.85M |
| 2025-11-30 | $9.15M |
| 2025-08-31 | $10.59M |
| 2025-05-31 | $9.77M |
| 2025-02-28 | $11.26M |
| 2024-11-30 | $15.78M |
| 2024-08-31 | $17.54M |
| 2024-05-31 | $18.58M |
| 2024-02-29 | $26.08M |
| 2023-11-30 | $32.27M |
| 2023-08-31 | $38.16M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.